Research Areas

You can also try the following methods, and our professionals will serve you Customized Consultation

Cat. No.	Product Name	Field of Application
DCAPI1496	Ambrisentan Featured	A nonpeptide endothelin ETA receptor antagonist. Antihypertensive.
DC11919	Arimoclomol Featured	A nontoxic heat shock protein (HSP) coinducer and potentiator of the heat shock response.
DC11920	Arimoclomol maleate Featured	A nontoxic, orally active heat shock protein (HSP) coinducer and potentiator of the heat shock response.
DC11523	Landipirdine	A novel 5-HT receptor antagonist for the treatment of Parkinson's disease..
DC11929	ME-344	A novel mitochondrial and mTOR inhibitor with potent anti-cancer activity, inhibits leukemia cell lines with IC50 of 70-260 nM.
DC11910	IPL-576092	A novel orally active, anti-inflammatory compound that inhibits leukocyte infiltration and changes in lung function in response to allergen challenge.
DC11811	SCY-078	A novel orally bioavailable fungal beta-1,3-D glucan synthetase inhibitor against Candida species C. glabrata (MIC 0.03 to 0.25 ug/ml), C. parapsilosis (MIC 0.06 to 0.25 ug/ml).
DC11515	Azeloprazole	A novel potent proton pump inhibitor that irreversibly inhibits H+,K+-ATPase activity with IC50 of 0.28 uM.
DC11607	JTZ-951(Enarodustat) Featured	A novel potent, orally active HIF prolyl hydroxylase (PHD) inhibitor with IC50 of 0.22 uM for PHD2.
DC11608	JTZ-951 hydrochloride	A novel potent, orally active HIF prolyl hydroxylase (PHD) inhibitor with IC50 of 0.22 uM for PHD2.
DC11546	Azeloprazole sodium	A novel potent, orally active proton pump inhibitor that irreversibly inhibits H+,K+-ATPase activity with IC50 of 0.28 uM.
DC11854	IDX899	A novel potent, selective HIV non-nucleoside reverse transcriptase inhibitor (NNRTI) with EC50 of 1, 1.3, 2.8 and 11 nM for WT, K103N, Y181C and K103N/Y181C, respectively.
DC11536	Imigliptin dihydrochloride	A novel potent, selective, orally available DPP-4 inhibitor with IC50 of 9 nM.
DC11631	INCB040093	A novel potent, selective, orally available PI3Kδ inhibitor with IC50 of 31 nM.
DC11547	LY-2562175 Featured	LY2562175 is a potent and selective FXR agonist, with an EC50 of 193 nM.
DC11908	Ralaniten	A novel small-molecule inhibitor of androgen receptor (AR) N-terminal domain inhibitor for the treatment of advanced prostate cancer.
DC11909	Ralaniten acetate	A novel small-molecule inhibitor of androgen receptor (AR) N-terminal domain inhibitor for the treatment of advanced prostate cancer.
DC11825	MK-8876	A novel, broadly acting non-nucleoside inhibitor of HCV NS5B polymerase with IC50 of 3 nM and 2 nM for GT1b and GT2a, respectively.
DC11799	G1T38	A novel, potent and selective inhibitor of CDK4/6 with biochemical IC50 of 1 nM and 2 nM for CDK4/cyclin D1 and CDK6/cyclin D3, respectively.
DC11800	G1T38 dihydrochloride	A novel, potent and selective inhibitor of CDK4/6 with biochemical IC50 of 1 nM and 2 nM for CDK4/cyclin D1 and CDK6/cyclin D3, respectively.
DC22584	Mavorixafor(AMD-070) Featured	A potent and selective antagonist of CXCR4 with IC50 of 13 nM in a CXCR4 125I-SDF inhibition binding assay.
DC11674	PF-DcpSi	A potent inhibitor of the mRNA decapping scavenger enzyme (DcpS) with IC50 of 0.11 nM.
DC11772	AZD-4316	A potent respiratory syncytial virus (RSV) fusion inhibitor..
DC11647	JNJ-2408068 Featured	JNJ 2408068 is a potent RSV (respiratory syncytial virus) inhibitor. JNJ2408068 significantly inhibits replication of RSV A and B subtypes in the lungs of cotton rats without any evidence of toxicity. The minimum protective dose of JNJ 2408068 appears to be approximately 0.39 mg/kg[1].
DC11641	Cridanimod Featured	A potent type I interferon (IFN) inducer that directly binds to STING and triggers a strong antiviral response through the TBK1/IRF3 route.
DC11533	PH-46A N-Methyl-D-Glucamine salt	A potent, first-in-class, oral small-molecule agent for the treatment of inflammatory bowel diseases..
DC11532	PH-46A	A potent, first-in-class, oral small-molecule agent for the treatment of inflammatory bowel diseases..
DC24010	Plpro-IN-6(PLpro inhibitor) Featured	A potent, noncovalent SARS-CoV papain-like protease (PLpro) inhibitor with IC50 of 2.6 uM.
DC11893	Firibastat	A potent, orally active, centrally acting aminopeptidase inhibitor, the prodrug of the specific and selective aminopeptidase A inhibitor EC33.
DC11518	Cavosonstat Featured	Cavosonstat is a potent, orally bioavailable inhibitor of S-nitrosoglutathione reductase (GSNOR) and CFTR modulator.

Research Areas

Customized Consultation X

Your information is safe with us. * Required Fields.